CLINICAL_TRIALS
trial_result
· 2018-02-13
Clinical Trial Update: CKD-11101 Phase 3 SC Study [Phase 3]
Summary
Phase 3 study of CKD-11101 in anemia of chronic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: COMPLETED